Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEK162 in Noonan Syndrome Hypertrophic Cardiomyopathy
This study has been withdrawn prior to enrollment.
(Study was withdrawn due to scientific and business considerations.)
Information provided by (Responsible Party):
First received: March 15, 2012
Last updated: December 28, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||No date given|
|Estimated Primary Completion Date:||May 2017 (Final data collection date for primary outcome measure)|